Exon skip ID | chr | Exons involved in exon skipping | Skipped exon |
exon_skip_162855 | chr8 | 74350434:74350578:74351274:74351466:74360137:74360248 | 74351274:74351466 |
exon_skip_176116 | chr8 | 74350444:74350578:74351274:74351321:74360137:74360248 | 74351274:74351321 |
exon_skip_211576 | chr8 | 74351298:74351466:74360137:74360310:74361884:74361978 | 74360137:74360310 |
exon_skip_240202 | chr8 | 74350444:74350578:74351274:74351466:74360137:74360248 | 74351274:74351466 |
exon_skip_240220 | chr8 | 74351274:74351321:74360137:74360310:74361884:74361978 | 74360137:74360310 |
exon_skip_244609 | chr8 | 74350444:74350578:74351274:74351466:74361884:74361978 | 74351274:74351466 |
exon_skip_285411 | chr8 | 74351426:74351466:74360137:74360310:74361884:74361978 | 74360137:74360310 |
exon_skip_30643 | chr8 | 74350434:74350578:74351274:74351321:74360137:74360248 | 74351274:74351321 |
exon_skip_94712 | chr8 | 74351274:74351466:74360137:74360310:74361884:74361978 | 74360137:74360310 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q8TB36 | 104 | 161 | 1 | 358 | Chain | ID=PRO_0000186038;Note=Ganglioside-induced differentiation-associated protein 1 |
Q8TB36 | 104 | 161 | 24 | 105 | Domain | Note=GST N-terminal |
Q8TB36 | 104 | 161 | 153 | 309 | Domain | Note=GST C-terminal |
Q8TB36 | 104 | 161 | 116 | 116 | Mutagenesis | Note=Impairment in the ability to induce mitochondrial fragmentation. M->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16172208;Dbxref=PMID:16172208 |
Q8TB36 | 104 | 161 | 157 | 157 | Mutagenesis | Note=No effect on mitochondrial localization. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15772096;Dbxref=PMID:15772096 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078265;Note=In CMT2K%3B dominant form. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=PMID:26525999 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_017184;Note=In CMT4A%3B no effect on mitochondrial localization but impairment in the ability to induce mitochondrial fragmentation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12601710,ECO:0000269|PubMed:1577 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078266;Note=In CMT2K%3B dominant form%3B no effect on mitochondrial localization. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs104 |
Q8TB36 | 104 | 161 | 123 | 123 | Natural variant | ID=VAR_078267;Note=In CMT2K%3B dominant form%3B. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515442,PMID:26525999,PMID:28244113 |
Q8TB36 | 104 | 161 | 126 | 126 | Natural variant | ID=VAR_078268;Note=In CMT2K%3B dominant form%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs879254005,PMID:28244113 |
Q8TB36 | 104 | 161 | 156 | 156 | Natural variant | ID=VAR_078269;Note=In CMT2K%3B dominant form. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515441,PMID:28244113 |
Q8TB36 | 104 | 161 | 161 | 161 | Natural variant | ID=VAR_017185;Note=In CMT4A%3B no effect on mitochondrial localization but abolishes mitochondrial fission. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11743579,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208 |
Q8TB36 | 104 | 161 | 133 | 133 | Sequence conflict | Note=M->I;Ontology_term=ECO:0000305;evidence=ECO:0000305 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q8TB36 | 104 | 161 | 1 | 358 | Chain | ID=PRO_0000186038;Note=Ganglioside-induced differentiation-associated protein 1 |
Q8TB36 | 104 | 161 | 24 | 105 | Domain | Note=GST N-terminal |
Q8TB36 | 104 | 161 | 153 | 309 | Domain | Note=GST C-terminal |
Q8TB36 | 104 | 161 | 116 | 116 | Mutagenesis | Note=Impairment in the ability to induce mitochondrial fragmentation. M->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16172208;Dbxref=PMID:16172208 |
Q8TB36 | 104 | 161 | 157 | 157 | Mutagenesis | Note=No effect on mitochondrial localization. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15772096;Dbxref=PMID:15772096 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078265;Note=In CMT2K%3B dominant form. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=PMID:26525999 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_017184;Note=In CMT4A%3B no effect on mitochondrial localization but impairment in the ability to induce mitochondrial fragmentation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12601710,ECO:0000269|PubMed:1577 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078266;Note=In CMT2K%3B dominant form%3B no effect on mitochondrial localization. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs104 |
Q8TB36 | 104 | 161 | 123 | 123 | Natural variant | ID=VAR_078267;Note=In CMT2K%3B dominant form%3B. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515442,PMID:26525999,PMID:28244113 |
Q8TB36 | 104 | 161 | 126 | 126 | Natural variant | ID=VAR_078268;Note=In CMT2K%3B dominant form%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs879254005,PMID:28244113 |
Q8TB36 | 104 | 161 | 156 | 156 | Natural variant | ID=VAR_078269;Note=In CMT2K%3B dominant form. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515441,PMID:28244113 |
Q8TB36 | 104 | 161 | 161 | 161 | Natural variant | ID=VAR_017185;Note=In CMT4A%3B no effect on mitochondrial localization but abolishes mitochondrial fission. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11743579,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208 |
Q8TB36 | 104 | 161 | 133 | 133 | Sequence conflict | Note=M->I;Ontology_term=ECO:0000305;evidence=ECO:0000305 |
UniProt acc. | Start of exon skipping (AA) | End of exon skipping (AA) | Protein feature start (AA) | Protein feature end (AA) | Category of protein feature | Description of feature |
Q8TB36 | 104 | 161 | 1 | 358 | Chain | ID=PRO_0000186038;Note=Ganglioside-induced differentiation-associated protein 1 |
Q8TB36 | 104 | 161 | 24 | 105 | Domain | Note=GST N-terminal |
Q8TB36 | 104 | 161 | 153 | 309 | Domain | Note=GST C-terminal |
Q8TB36 | 104 | 161 | 116 | 116 | Mutagenesis | Note=Impairment in the ability to induce mitochondrial fragmentation. M->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16172208;Dbxref=PMID:16172208 |
Q8TB36 | 104 | 161 | 157 | 157 | Mutagenesis | Note=No effect on mitochondrial localization. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15772096;Dbxref=PMID:15772096 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078265;Note=In CMT2K%3B dominant form. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26525999;Dbxref=PMID:26525999 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_017184;Note=In CMT4A%3B no effect on mitochondrial localization but impairment in the ability to induce mitochondrial fragmentation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12601710,ECO:0000269|PubMed:1577 |
Q8TB36 | 104 | 161 | 120 | 120 | Natural variant | ID=VAR_078266;Note=In CMT2K%3B dominant form%3B no effect on mitochondrial localization. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs104 |
Q8TB36 | 104 | 161 | 123 | 123 | Natural variant | ID=VAR_078267;Note=In CMT2K%3B dominant form%3B. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26525999,ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515442,PMID:26525999,PMID:28244113 |
Q8TB36 | 104 | 161 | 126 | 126 | Natural variant | ID=VAR_078268;Note=In CMT2K%3B dominant form%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs879254005,PMID:28244113 |
Q8TB36 | 104 | 161 | 156 | 156 | Natural variant | ID=VAR_078269;Note=In CMT2K%3B dominant form. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28244113;Dbxref=dbSNP:rs397515441,PMID:28244113 |
Q8TB36 | 104 | 161 | 161 | 161 | Natural variant | ID=VAR_017185;Note=In CMT4A%3B no effect on mitochondrial localization but abolishes mitochondrial fission. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11743579,ECO:0000269|PubMed:15772096,ECO:0000269|PubMed:16172208 |
Q8TB36 | 104 | 161 | 133 | 133 | Sequence conflict | Note=M->I;Ontology_term=ECO:0000305;evidence=ECO:0000305 |